Vitamin pills increase mortality

Denmark - Vitamins A, E and beta carotene, taken singly or with other supplements, 'significantly increase mortality' according to a review study released by the Cochrane Hepato-Biliary Group* at Copenhagen University Hospital. Their study, published in the Journal of the American Medical Association (JAMA), did not find evidence that vitamin C could increase longevity, but did find that selenium tended to reduce the risk of death.

The Copenhagen researchers analysed 68 previous trials of the five antioxidant supplements, involving 232,606 participants, and say their findings contradict those of observational studies that claim antioxidants improve health. ‘Considering that 10-20% of the adult population (80-160 million people) in North America and Europe may consume the assessed supplements, the public health consequences may be substantial.’

The team reported that 47 ‘low-bias risk’ trials, with 180,938 participants, were ‘best quality’. Based on those low-bias studies, vitamin supplements were found to be associated with a 5% increased risk of mortality. Beta carotene was associated with a 7% risk, vitamin A with a 16% risk and vitamin E with a 4% risk. No increased mortality risk with vitamin C or selenium were seen.

* The Cochrane is an international network of experts who carry out systematic reviews of scientific evidence on health interventions.

08.03.2007

More on the subject:

Related articles

Photo

News • Preventive strategies

Blocking tick saliva could stop deadly infections

A tick's saliva keeps blood flowing, disarms the immune system, and smuggles in pathogens like the bacteria behind Lyme disease. Scientists have just found out how to disrupt this process and…

Photo

News • Ependymoma and medulloblastoma tumoroids

New organoids offer deeper insights into pediatric brain cancer

Patient-derived organoids (PDOs), or tumoroids, for pediatric brain cancer show promise in helping researchers find new drugs and better understand the different responses of the tumor.

Photo

News • Dynamic in vitro platform

“Breathing” organoid offers new insights into lung disease

A new type of “breathing” lung organoid enables quantitative measurement of how easily the lung expands - and may provide a new way to study diseases such as pulmonary fibrosis.

Subscribe to Newsletter